Hypertrophic cardiomyopathy (HCM) is an often hereditary disease of the heart muscles and occurs in approximately one in 500 people. Progressive thickening of the walls of the left ventricle can lead to shortness of breath, fainting, chest pain and cardiac arrhythmia, and even sudden cardiac death. HCM remains undiagnosed for a long time and requires intensive collaboration between cardiologists, cardiac surgeons and human geneticists, both in terms of diagnosis and treatment.
In our special outpatient clinic (cardio), we examine the HCM disease in detail and develop the optimum diagnosis and treatment strategy. We also carry out differential diagnostic investigations of unclear cardiac cardiomyopathies (e.g. cardiac amyloidosis, Fabry disease) and initiate targeted therapy.